Impact of the longitudinal evolution of impaired fasting glucose on cardio-kidney-metabolic multimorbidity - Scorecard - MDSpire

Impact of the longitudinal evolution of impaired fasting glucose on cardio-kidney-metabolic multimorbidity

  • By

  • Guanlin Chen

  • Hong Zheng

  • Yuxian Wang

  • Man Gui

  • Zhen He

  • Zekai Chen

  • Shouling Wu

  • Youren Chen

  • June 16, 2026

  • 0 min

Share

Clinical Scorecard: Longitudinal Patterns of Impaired Fasting Glucose and Their Relationship with Cardio-Kidney-Metabolic Multimorbidity Risk

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationAdults aged 18 and older free of cardiovascular disease, type 2 diabetes, and chronic kidney disease at baseline.
Care Setting

Key Highlights

  • Persistent IFG is defined as IFG that remains over multiple assessments.

Guideline-Based Recommendations

Diagnosis

    Management

    • Preventing the onset of IFG should be prioritized, followed by timely intervention after its occurrence, including lifestyle changes and potential pharmacotherapy.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Management should focus on maintaining normal fasting glucose levels through lifestyle modifications and pharmacotherapy to mitigate long-term multisystem damage.

        Clinical Best Practices

        • Early prevention of IFG through lifestyle interventions and regular monitoring.
        • Sustained maintenance of normal fasting glucose with evidence-based strategies.

        Related Resources & Content

        Original Source(s)

        Related Content